Fycompa 2 mg film-coated tablets
Sponsors
Universitaetsklinikum Heidelberg AöR, Eisai Limited, Istituto Di Ricovero E Cura A Carattere Scientifico Materno Infantile Burlo Garofolo
Conditions
Childhood EpilepsyProgressive GlioblastomaWhite-Sutton syndrome (POGZ-Related Disorder)
Phase 2
Clinical and translational controlled study of Perampanel treatment around Surgery in patients with progressive glioblastoma (PerSurge)
RecruitingCTIS2023-503938-52-00
Start: 2024-01-26Target: 66Updated: 2024-09-20
An Open-Label Study with Extension Phase to Evaluate the Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Subjects (Age 1 Month to Less Than 18 Years) With Childhood Epilepsy
RecruitingCTIS2023-507794-17-00
Start: 2019-11-11Target: 54Updated: 2025-09-19
A Multicentric, Drug-Repositioning, Self Controlled Case Series (SCCS) Clinical Trial to Evaluate the Efficacy and Safety of Perampanel in Improving Behavioral Symptoms and Increasing the Quality of Life in Patients with White-Sutton syndrome (POGZ-Related Disorder)
Not yet recruitingCTIS2025-520611-14-00
Target: 41Updated: 2025-11-03